Assessment of Cardiovascular Function in Childhood Leukemia Survivors: The Role of the Right Heart

Overview

Journal Children (Basel)

Specialty Health Services

Date 2022 Nov 24

PMID 36421180

Authors

Paola Muggeo

Pietro Scicchitano

Vito Michele Rosario Muggeo

Chiara Novielli

Paola Giordano

Marco Matteo Ciccone

Maria Felicia Faienza

Nicola Santoro

Affiliations

Soon will be listed here.

Abstract

Childhood acute lymphoblastic leukemia (ALL) survivors who underwent chemotherapy with anthracyclines have an increased cardiovascular risk. The aim of the study was to evaluate left and right cardiac chamber performances and vascular endothelial function in childhood ALL survivors. Fifty-four ALL survivors and 37 healthy controls were enrolled. All patients underwent auxological evaluation, blood pressure measurements, biochemical parameters of endothelial dysfunction, flow-mediated dilatation (FMD) of the brachial artery, mean common carotid intima-media thickness (c-IMT), antero-posterior diameter of the infra-renal abdominal aorta (APAO), and echocardiographic assessment. The ALL subjects had significantly lower FMD (p = 0.0041), higher left (p = 0.0057) and right (p = 0.0021) echocardiographic/Doppler Tei index (the non-invasive index for combined systolic and diastolic ventricular function) as compared to controls. Tricuspid annular plane excursion (TAPSE) was 16.9 ± 1.2 mm vs. 24.5 ± 3.7 mm, p < 0.0001. Cumulative anthracycline doses were related to TAPSE (p < 0.001). The ALL survivors treated with anthracyclines demonstrated systo/diastolic alterations of the right ventricle and reduced endothelial function compared with healthy controls. The early recognition of subclinical cardiac and vascular impairment during follow up is of utmost importance for the cardiologist to implement strategies preventing overt cardiovascular disease considering the growing number of young adults cured after childhood ALL.

References

Cetin S, Babaoglu K, Basar E, Deveci M, Corapcioglu F . Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography. Echocardiography. 2017; 35(2):234-240. DOI: 10.1111/echo.13743. View

Dengel D, Ness K, Glasser S, Williamson E, Baker K, Gurney J . Endothelial function in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2008; 30(1):20-5. DOI: 10.1097/MPH.0b013e318159a593. View

Chow A, Chin C, Dahl G, Rosenthal D . Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study. J Clin Oncol. 2006; 24(6):925-8. DOI: 10.1200/JCO.2005.03.5956. View

Kaneko S, Tham E, Haykowsky M, Spavor M, Khoo N, Mackie A . Impaired Left Ventricular Reserve in Childhood Cancer Survivors Treated With Anthracycline Therapy. Pediatr Blood Cancer. 2016; 63(6):1086-90. DOI: 10.1002/pbc.25933. View

Guazzi M, Bandera F, Pelissero G, Castelvecchio S, Menicanti L, Ghio S . Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol. 2013; 305(9):H1373-81. DOI: 10.1152/ajpheart.00157.2013. View

Bayram C, Cetin I, Tavil B, Yarali N, Ekici F, Isik P . Evaluation of cardiotoxicity by tissue Doppler imaging in childhood leukemia survivors treated with low-dose anthracycline. Pediatr Cardiol. 2015; 36(4):862-6. DOI: 10.1007/s00246-015-1096-6. View

Ciccone M, Favale S, Bhuva A, Scicchitano P, Caragnano V, Lavopa C . Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome. Vasc Health Risk Manag. 2009; 5(3):561-6. PMC: 2704897. DOI: 10.2147/vhrm.s5639. View

Pluimakers V, van Waas M, Neggers S, van den Heuvel-Eibrink M . Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors. Crit Rev Oncol Hematol. 2019; 133:129-141. DOI: 10.1016/j.critrevonc.2018.10.010. View

Mulrooney D, Hyun G, Ness K, Bhakta N, Pui C, Ehrhardt M . The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study. Lancet Haematol. 2019; 6(6):e306-e316. PMC: 6756152. DOI: 10.1016/S2352-3026(19)30050-X. View

10.

Larose E, Ganz P, Reynolds H, Dorbala S, Di Carli M, Brown K . Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol. 2007; 49(8):855-62. DOI: 10.1016/j.jacc.2006.10.056. View

11.

Tei C . New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol. 1995; 26(2):135-6. View

12.

Jenei Z, Bardi E, Magyar M, Horvath A, Paragh G, Kiss C . Anthracycline causes impaired vascular endothelial function and aortic stiffness in long term survivors of childhood cancer. Pathol Oncol Res. 2012; 19(3):375-83. DOI: 10.1007/s12253-012-9589-6. View

13.

Corretti M, Anderson T, Benjamin E, Celermajer D, Charbonneau F, Creager M . Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002; 39(2):257-65. DOI: 10.1016/s0735-1097(01)01746-6. View

14.

Seara F, Kasai-Brunswick T, Nascimento J, Campos-de-Carvalho A . Anthracycline-induced cardiotoxicity and cell senescence: new therapeutic option?. Cell Mol Life Sci. 2022; 79(11):568. PMC: 11803035. DOI: 10.1007/s00018-022-04605-7. View

15.

Naseem M, Alkassas A, Alaarag A . Tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio as a predictor of in-hospital mortality for acute heart failure. BMC Cardiovasc Disord. 2022; 22(1):414. PMC: 9482278. DOI: 10.1186/s12872-022-02857-6. View

16.

Kocabas A, Kardelen F, Ertug H, Aldemir-Kocabas B, Tosun O, Yesilipek A . Assessment of early-onset chronic progressive anthracycline cardiotoxicity in children: different response patterns of right and left ventricles. Pediatr Cardiol. 2013; 35(1):82-8. DOI: 10.1007/s00246-013-0745-x. View

17.

Hader S, Zinkevich N, Norwood Toro L, Kriegel A, Kong A, Freed J . Detrimental effects of chemotherapy on human coronary microvascular function. Am J Physiol Heart Circ Physiol. 2019; 317(4):H705-H710. PMC: 6843017. DOI: 10.1152/ajpheart.00370.2019. View

18.

Bergler-Klein J . Right from the heart: survivors of childhood cancer and the right ventricle. Eur Heart J Cardiovasc Imaging. 2016; 17(7):742-3. DOI: 10.1093/ehjci/jew052. View

19.

Elbl L, Hrstkova H, Chaloupka V . The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer. Eur J Pediatr. 2003; 162(10):690-6. DOI: 10.1007/s00431-003-1275-y. View

20.

Ogden C, Flegal K, Carroll M, Johnson C . Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002; 288(14):1728-32. DOI: 10.1001/jama.288.14.1728. View